Neoadjuvant J591 Treatment for Prostate Cancer (Q65393916)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neoadjuvant J591 Treatment for Prostate Cancer |
clinical trial |
Statements
A Pilot Study of Neoadjuvant Monoclonal Antibody Humanised (hu) J591 for the Treatment of High and/or Intermediate−Risk Prostate Cancer (English)
0 references
4 February 2016
0 references
10 February 2017
0 references
10
0 references
18 year
0 references